CLINICAL_TRIALS
trial_result
· 2010-03-04
Clinical Trial Update: RNF and Betaseron® Tolerability Study [Phase 3]
Summary
A Phase 3 tolerability study evaluating RNF and Betaseron in relapsing-remitting multiple sclerosis has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono | Conditions: Relapsing Remitting Multiple Sclerosis (RRMS) | Phase 3 | Status: COMPLETED | Results posted: 2010-03-04